CASH COLLECT CERTIFICATE AUTOCALLABLE - BIONTECH ADR/BIOGEN IDEC/CUREVAC CASH COLLECT CERTIFICATE AUTOCALLABLE - BIONTECH ADR/BIOGEN IDEC/CUREVAC Stock
Certificat
UV8CQ8
DE000HV8CQ89
| Market Closed - Borsa Italiana 11:44:59 2024-04-26 EDT | ||
| 4.28 EUR | +0.23% |
|
| Current month | -25.44% | ||
| 1 month | -22.04% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 4.28 | +0.23% | 48 |
| 24-04-25 | 4.27 | -4.04% | 200 |
| 24-04-24 | 4.45 | -5.92% | 54 |
| 24-04-23 | 4.73 | +3.28% | 52 |
| 24-04-22 | 4.58 | +3.15% | 29 |
Real-time Borsa Italiana
Last update April 26, 2024 at 11:44 am
More quotesStatic data
| Product type | Other Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| UV8CQ8 | |
| ISIN | DE000HV8CQ89 |
| Date issued | 2021-07-21 |
| Maturity | 2024-05-16 (18 Days) |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 111.7 € |
|---|---|
| Lowest since issue | 4.21 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
208.9
USD
Average target price
286
USD
Spread / Average Target
+36.89%
- Stock Market
- Certificates
- UV8CQ8 Certificat
